Price $0.82 |
Market Cap
521M
|
Sector Health Care |
Div. Growth
-
|
|
P/E
-
|
P/B
1.5
|
P/S
0.15
|
Dividend %
-
|
|
P/CF
-
|
P/FCF
-
|
Op. Cash Flow
-203.9K
|
FCF
-0.4
|
|
Op. Margin
-10.00%
|
Net Margin
-9.70%
|
ROE
-81.80%
|
ROI
-100.00%
|
|
ROA
-19.10%
|
EPS Growth
50.40%
|
Current Ratio
1.4
|
Debt/Equity
-
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Emmaus Life Sciences Inc (EMMA) | $0.33 | - | - | 19.2M | Strong Buy |
| DURECT Corp (DRRX) | $4.32 | - | - | 110.1M | Strong Buy |
| Dare Bioscience Inc (DARE) | $1.06 | - | - | 95M | Strong Buy |
| Avalo Therapeutics Inc (AVTX) | $1.75 | - | - | 32.3M | Strong Buy |
| Akumin Inc (AKU) | $0.70 | - | - | 108.7M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
